advanced

Bharath Advanced Therapeutics (BAT) and FABA Present Cancer NEXT 2024: Pioneering Innovation in Cancer Research

HYDERABAD, India, Nov. 29, 2024 /PRNewswire/ -- Bharath Advanced Therapeutics (BAT) and the Federation of Asian Biotech Associations (FABA) are…

3 weeks ago

Launch of the 2025/2027 edition of the Advanced Olympic Research Grant Programme

26 November 2024 - The IOC Olympic Studies Centre (OSC) has launched a new edition of the Advanced Olympic Research Grant Programme intended…

3 weeks ago

Launch of the 2025/2027 edition of the Advanced Olympic Research Grant Programme

26 November 2024 - The IOC Olympic Studies Centre (OSC) has launched a new edition of the Advanced Olympic Research Grant Programme intended…

4 weeks ago

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…

4 weeks ago

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…

4 weeks ago

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…

4 weeks ago

Anocca Announces Submission of Clinical Trial Application for Multi-asset Trial VIDAR-1 in Advanced Pancreatic Cancer

November 26, 2024 03:00 ET | Source: Anocca AB Application to the European Medicines Agency (EMA) covers ANOC-001 as the…

4 weeks ago

Protecht launches advanced controls management solution

SYDNEY, Nov. 25, 2024 /PRNewswire/ -- Protecht Group, a global leader in enterprise risk management solutions, has released its innovative…

4 weeks ago

Protecht launches advanced controls management solution

SYDNEY, Nov. 25, 2024 /PRNewswire/ -- Protecht Group, a global leader in enterprise risk management solutions, has released its innovative…

4 weeks ago

IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer

FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule,…

4 weeks ago